Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - interferon beta-1a - injection, solution - 22mcg/0.5ml - interferon beta-1a 22mcg/0.5ml

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - interferon beta-1a - injection, solution - 44mcg/0.5ml - interferon beta-1a 44mcg/0.5ml

Israel - English - Ministry of Health

merck serono ltd - interferon beta 1a - solution for injection - interferon beta 1a 44 mcg/ml - interferon beta-1a - interferon beta-1a - rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. efficacy of rebif in chronic progressive multiple sclerosis has not been established.

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - interferon beta-1a - injection, solution - 22mcg/0.5ml

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - interferon beta-1a - injection, solution - 44 mcg/0.5ml

European Union - English - EMA (European Medicines Agency)

merck europe b.v.  - interferon beta-1a - multiple sclerosis - immunostimulants, - rebif is indicated for the treatment of:patients with a single demyelinating event with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing multiple sclerosis. in clinical trials, this was characterised by two or more acute exacerbations in the previous two years.efficacy has not been demonstrated in patients with secondary progressive multiple sclerosis without ongoing relapse activity.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

12million units - interferon beta-1a - solution for injection - 24mega u/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

6million units - interferon beta-1a - solution for injection - 12mega u/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

6million units - not applicable

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

6million units - interferon beta-1a - solution for injection - 12mega u/1ml